Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05084924 · ClinicalTrials.gov registry record · NA
Investigating the Causal Role of Prefrontal Control in Decision-making in Patients With Anhedonia
A NA study, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- NA
- Development phase
- 35
- Enrollment target
NCT05084924 is a NA study that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 35 participants.
The verdict
NCT05084924, a NA study, has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- NA
- Development phase
- 35 participants
- Enrollment target
Study Summary
Investigating whether delta-beta cross-frequency transcranial alternating current stimulation can increase goal-directed behavior in participants with major depressive disorder and elevated symptoms of anhedonia.
Interventions
- DEVICE Cross-frequency transcranial alternating current stimulation via the NeuroConn Direct Current Stimulator Plus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2021-11-02 |
| Est. Completion | 2023-07-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05084924
The ClinicalTrials.gov registry entry for NCT05084924 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 35 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Cross-frequency transcranial alternating current stimulation via the NeuroConn Direct Current Stimulator Plus is the first listed.
NCT05084924 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05084924 about?
NCT05084924 is a clinical study titled "Investigating the Causal Role of Prefrontal Control in Decision-making in Patients With Anhedonia". Investigating whether delta-beta cross-frequency transcranial alternating current stimulation can increase goal-directed behavior in participants with major depressive disorder and elevated symptoms of anhedonia.
What is the current status of trial NCT05084924?
This trial is currently completed. It is a NA study. The enrollment target is 35 participants. The study started on 2021-11-02. Estimated completion is 2023-07-31.
What interventions are being tested in trial NCT05084924?
The interventions under investigation include: Cross-frequency transcranial alternating current stimulation via the NeuroConn Direct Current Stimulator Plus (DEVICE).
Who is sponsoring clinical trial NCT05084924?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.